SectorPharmaceutical
Established Date--
Listing Date08/01/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees109
Fiscal Year Ends31/12
Security TypeCommon stock
Office addressOne Main Street, Suite 1350, Cambridge, MA 02142
Business
IntroductionCullinan Therapeutics, Inc., is incorporated in Delaware. The company is a biopharmaceutical company focused on developing a diverse pipeline of tumor-targeted therapies and immuno-oncology therapies with translational potential for cancer patients.
